RECURRENT ASTROCYTOMA, GRADE IV

Clinical trials for RECURRENT ASTROCYTOMA, GRADE IV explained in plain language.

Never miss a new study

Get alerted when new RECURRENT ASTROCYTOMA, GRADE IV trials appear

Sign up with your email to follow new studies for RECURRENT ASTROCYTOMA, GRADE IV, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

Brain tumor trial explores immune drug with radiation

Disease control Ongoing

This early-phase trial tests whether adding the drug mycophenolate mofetil (MMF) to radiation therapy is safe for people with glioblastoma, an aggressive brain cancer. About 68 participants with newly diagnosed or recurrent glioblastoma will receive MMF alongside radiation. The m…

Matched conditions: RECURRENT ASTROCYTOMA, GRADE IV

Phase: PHASE1 • Sponsor: University of Michigan Rogel Cancer Center • Aim: Disease control

Last updated May 15, 2026 11:57 UTC

RECURRENT ASTROCYTOMA, GRADE IV

Get alerted when new RECURRENT ASTROCYTOMA, GRADE IV trials appear

Brain tumor trial explores immune drug with radiation